Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
- 31 December 2004
- journal article
- review article
- Published by Elsevier BV in Drug Resistance Updates
- Vol. 7 (6), 325-331
- https://doi.org/10.1016/j.drup.2004.10.002
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast CancerJournal of Clinical Oncology, 2004
- The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2003
- Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerThe Lancet, 2003
- Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differencesDrug Resistance Updates, 2003
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcomeBritish Journal of Cancer, 2003
- Chemotherapy for metastatic breast cancer–report of a European expert panelThe Lancet Oncology, 2002
- Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast CancerThe Cancer Journal, 2002
- 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*Journal of Clinical Oncology, 2001
- Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast CancerJournal of Clinical Oncology, 1999